Position in SVRA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,146,197
+$288,202 QoQ
Shares Held
186,071
+18.4% QoQ
Ownership
0.091%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#64
of 181 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 23%
Shared 0%
None 77%
Common Shares in SVRA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. SVRA ranks #125 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in SVRA
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,146,197 | 186,071 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $857,995 | 157,142 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $921,233 | 152,775 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $562,514 | 157,567 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $388,001 | 170,176 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $425,311 | 153,542 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $434,174 | 141,425 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $561,308 | 132,384 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $542,228 | 134,548 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $666,966 | 133,929 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $611,300 | 130,064 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $459,398 | 121,534 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $319,621 | 100,038 | Shares | Sole | 2023-08-08 | |
| 2021-03-31 | $145,907 | 70,148 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $81,475 | 70,848 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $66,177 | 60,713 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $175,701 | 70,563 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $86,235 | 40,677 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||